Advanced Therapies Journal

Advanced Therapies Journal

The Influence of Host Genetic Variants on Clinical Severity and Antiviral Therapy Response in Respiratory Viral Infections

Reviewers

Author
Mehrab Khazaie ΒΆ
Department of Cell and Molecular Biology, Islamic Azad University, Tehran East Branch, Tehran, Iran.
10.22034/atj.2026.250918
Abstract
Autoimmune disorders are complex conditions that result from a combination of genetic and environmental causes and currently have no recognized therapy. Various therapeutic strategies may be used in various illnesses to promote remission or, at the very least, alleviate the symptoms. For customized therapy to be implemented, it is necessary to identify groups of individuals who are generally similar and share pathogenic signaling pathways. Therefore, research about autoimmune disorders mainly focuses on identifying new biomarkers, uncovering novel targets for therapy and agents, and understanding the processes involved in developing various disorders. We are just at the nascent phase of implementing tailored therapy for autoimmune illnesses. Hence, this research delved into the examination of several autoimmune illnesses and the impact of personalized therapy on their progression.
Keywords
Host Genetic Variations, Respiratory Viral Infections, Disease Severity
Pharmacogenomics, Precision Medicine
Advanced Therapies Journal
Volume 8, Issue 27
Spring 2026
Pages 41-50

  • Receive Date 18 February 2026
  • Revise Date 13 April 2026
  • Accept Date 22 May 2026